193 related articles for article (PubMed ID: 26358398)
61. MicroRNA-204 inhibits the proliferation and metastasis of breast cancer cells by targeting PI3K/AKT pathway.
Fan X; Fang X; Liu G; Xiong Q; Li Z; Zhou W
J BUON; 2019; 24(3):1054-1059. PubMed ID: 31424660
[TBL] [Abstract][Full Text] [Related]
62. Regulation of AKT phosphorylation by GSK3β and PTEN to control chemoresistance in breast cancer.
Gao C; Yuan X; Jiang Z; Gan D; Ding L; Sun Y; Zhou J; Xu L; Liu Y; Wang G
Breast Cancer Res Treat; 2019 Jul; 176(2):291-301. PubMed ID: 31006103
[TBL] [Abstract][Full Text] [Related]
63. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
[TBL] [Abstract][Full Text] [Related]
64. Cyclopeptide RA-V inhibits cell adhesion and invasion in both estrogen receptor positive and negative breast cancer cells via PI3K/AKT and NF-κB signaling pathways.
Leung HW; Wang Z; Yue GG; Zhao SM; Lee JK; Fung KP; Leung PC; Lau CB; Tan NH
Biochim Biophys Acta; 2015 Aug; 1853(8):1827-40. PubMed ID: 25953046
[TBL] [Abstract][Full Text] [Related]
65. Downregulation of TBC1 Domain Family Member 24 (BC1D24) Inhibits Breast Carcinoma Growth via IGF1R/PI3K/AKT Pathway.
Qu X; Zhao B; Hu M; Ji Z; Xu J; Xia W; Qu Y
Med Sci Monit; 2018 Jun; 24():3987-3996. PubMed ID: 29893377
[TBL] [Abstract][Full Text] [Related]
66. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
[TBL] [Abstract][Full Text] [Related]
67. SMURF1 plays a role in EGF-induced breast cancer cell migration and invasion.
Kwon A; Lee HL; Woo KM; Ryoo HM; Baek JH
Mol Cells; 2013 Dec; 36(6):548-55. PubMed ID: 24241683
[TBL] [Abstract][Full Text] [Related]
68. MCT-1 expression and PTEN deficiency synergistically promote neoplastic multinucleation through the Src/p190B signaling activation.
Wu MH; Chen YA; Chen HH; Chang KW; Chang IS; Wang LH; Hsu HL
Oncogene; 2014 Oct; 33(43):5109-20. PubMed ID: 24858043
[TBL] [Abstract][Full Text] [Related]
69. Cyclic phosphatidic acid inhibits RhoA-mediated autophosphorylation of FAK at Tyr-397 and subsequent tumor-cell invasion.
Mukai M; Iwasaki T; Tatsuta M; Togawa A; Nakamura H; Murakami-Murofushi K; Kobayashi S; Imamura F; Inoue M
Int J Oncol; 2003 Jun; 22(6):1247-56. PubMed ID: 12738990
[TBL] [Abstract][Full Text] [Related]
70. Fbxw7 regulates tumor apoptosis, growth arrest and the epithelial-to-mesenchymal transition in part through the RhoA signaling pathway in gastric cancer.
Li H; Wang Z; Zhang W; Qian K; Xu W; Zhang S
Cancer Lett; 2016 Jan; 370(1):39-55. PubMed ID: 26458995
[TBL] [Abstract][Full Text] [Related]
71. MicroRNA-146a inhibits cell migration and invasion by targeting RhoA in breast cancer.
Liu Q; Wang W; Yang X; Zhao D; Li F; Wang H
Oncol Rep; 2016 Jul; 36(1):189-96. PubMed ID: 27175941
[TBL] [Abstract][Full Text] [Related]
72. The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway.
Wan W; Hou Y; Wang K; Cheng Y; Pu X; Ye X
Cell Death Dis; 2019 Mar; 10(3):248. PubMed ID: 30867411
[TBL] [Abstract][Full Text] [Related]
73. Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton.
Fu XD; Giretti MS; Baldacci C; Garibaldi S; Flamini M; Sanchez AM; Gadducci A; Genazzani AR; Simoncini T
PLoS One; 2008 Jul; 3(7):e2790. PubMed ID: 18665217
[TBL] [Abstract][Full Text] [Related]
74. IP
Vautrin-Glabik A; Botia B; Kischel P; Ouadid-Ahidouch H; Rodat-Despoix L
Biochim Biophys Acta Mol Cell Res; 2018 Jul; 1865(7):945-958. PubMed ID: 29630900
[TBL] [Abstract][Full Text] [Related]
75. The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.
Cardone RA; Bellizzi A; Busco G; Weinman EJ; Dell'Aquila ME; Casavola V; Azzariti A; Mangia A; Paradiso A; Reshkin SJ
Mol Biol Cell; 2007 May; 18(5):1768-80. PubMed ID: 17332506
[TBL] [Abstract][Full Text] [Related]
76. Lysophosphatidic acid activates the RhoA and NF-κB through Akt/IκBα signaling and promotes prostate cancer invasion and progression by enhancing functional invadopodia formation.
Hwang YS; Lee J; Zhang X; Lindholm PF
Tumour Biol; 2016 May; 37(5):6775-85. PubMed ID: 26662305
[TBL] [Abstract][Full Text] [Related]
77. CCL2 promotes lymphatic metastasis via activating RhoA and Rac1 pathway and predict prognosis to some extent in tongue cancer.
Dong Y; Zhang S; Zhao S; Xuan M; Zhu G; Zhang Z; Guo W
Cancer Biol Ther; 2023 Dec; 24(1):2205342. PubMed ID: 37132640
[TBL] [Abstract][Full Text] [Related]
78. Hypoxia-induced ARHGAP26 deficiency inhibits the proliferation and migration of human ductus arteriosus smooth muscle cell through activating RhoA-ROCK-PTEN pathway.
Li M; Ye L; Ye X; Wang S; Zhang H; Liu J; Hong H
J Cell Biochem; 2019 Jun; 120(6):10106-10117. PubMed ID: 30592323
[TBL] [Abstract][Full Text] [Related]
79. Overexpression of RhoA-GTP induces activation of the Epidermal Growth Factor Receptor, dephosphorylation of focal adhesion kinase and increased motility in breast cancer cells.
Cáceres M; Guerrero J; Martínez J
Exp Cell Res; 2005 Sep; 309(1):229-38. PubMed ID: 15963982
[TBL] [Abstract][Full Text] [Related]
80. The RhoA pathway mediates MMP-2 and MMP-9-independent invasive behavior in a triple-negative breast cancer cell line.
Fagan-Solis KD; Schneider SS; Pentecost BT; Bentley BA; Otis CN; Gierthy JF; Arcaro KF
J Cell Biochem; 2013 Jun; 114(6):1385-94. PubMed ID: 23255405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
